BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7131236)

  • 1. Effect of pyrimidines, purines and their nucleosides on antitumor activity of 5-fluorouracil against L-1210 leukemia.
    Iigo M; Ando N; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1982 Jul; 5(7):515-20. PubMed ID: 7131236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1980 Jan; 64(1):69-72. PubMed ID: 6928048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the chemotherapeutic action of 5-fluorouracil by combination with cytidine or guanosine on HRS-sarcoma.
    Osswald H; Youssef M
    J Cancer Res Clin Oncol; 1979 Apr; 93(3):241-4. PubMed ID: 381315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of nucleoside and pyrimidine base metabolism in Corynebacterium glutamicum].
    Grishchenkov VG; Sukhodolets VV; Smirnov IuV
    Mikrobiologiia; 1978; 47(4):693-8. PubMed ID: 151772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation.
    Tezuka M; Tamemasa O
    Jpn J Exp Med; 1983 Jun; 53(3):155-63. PubMed ID: 6663806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
    Hartmann HR; Bollag W
    Med Oncol Tumor Pharmacother; 1986; 3(2):111-8. PubMed ID: 2943952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
    Jato J; Windheuser JJ
    J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation by guanine nucleosides of the growth-inhibitory effects of adenosine analogs on L1210 and sarcoma 180 cells in culture.
    Grindey GB; Lowe JK; Divekar AY; Hakala MT
    Cancer Res; 1976 Feb; 36(2 Pt 1):379-83. PubMed ID: 944090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ribonucleosides, deoxyribonucleosides, and purine and pyrimidine bases in adult rabbit cerebrospinal fluid and plasma.
    Eells JT; Spector R
    Neurochem Res; 1983 Oct; 8(10):1307-20. PubMed ID: 6656989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
    Tezuka M; Chiba Y; Okada S; Tamemasa O
    J Pharmacobiodyn; 1986 Aug; 9(8):683-7. PubMed ID: 3783412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.